{"transactions":[{"id":998986,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true}}],"security":"Stock Options (right to buy)","published_at":"2025-11-14T16:07:16.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest on November 12, 2026, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":164001,"derivative":{"exercise_price":0.49,"exercise_date":"2026-11-12","expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-25-035179","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000143774925035179/rdgdoc.xml","form_type":"4"}},{"id":1374352,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2024-11-06T20:06:10.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest through April 2025, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":14001,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001437749-24-033710","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000143774924033710/rdgdoc.xml","form_type":"4"}},{"id":1876748,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2023-05-26T17:16:43.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest on the earlier of one year from the date of the Company's 2023 annual meeting of stockholders or on the next annual meeting of stockholders, subject to the grantee's continued service on the Company's Board of Directors on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":0.62,"expiration_date":"2033-05-25","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-23-016005","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000143774923016005/rdgdoc.xml","form_type":"4"}},{"id":2224331,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2022-06-22T19:02:36.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options set forth in this table vest on the earlier of one year from the date of the Company's 2022 annual meeting of stockholders or on the date of the next annual meeting of stockholders, subject the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.49,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-22-015658","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000143774922015658/rdgdoc.xml","form_type":"4"}},{"id":2224330,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2022-06-22T19:02:36.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":23333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.49,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":23333},"source":{"system":"sec-edgar","filing":"0001437749-22-015658","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000143774922015658/rdgdoc.xml","form_type":"4"}},{"id":2251626,"issuer":{"id":126718,"kind":"organization","name":"Checkmate Pharmaceuticals, Inc.","symbol":"CMPI"},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-31T10:06:35.000Z","date":"2022-05-31","kind":"disposition_to_issuer","acquired":false,"shares":20061,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"At the effective time of the merger contemplated by the Agreement and Plan of Merger dated April 18, 2022, among Checkmate Pharmaceuticals, Inc. (the \"Issuer\"), Regeneron Pharmaceuticals, and Scandinavian Acquisition Sub, Inc. (the \"Merger\"), each option granted by the Issuer to purchase Issuer Common Stock, whether or not vested, which has a per share exercise price that is less than $10.50 (each, an \"In the Money Issuer Option\") that was outstanding and unexercised as of immediately prior to the effective time of the Merger was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the total number of Issuer Common Stock subject to such In the Money Issuer Option and (2) the excess of $10.50 over the exercise price of such In the Money Issuer Option, subject to any required withholding of taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"At the effective time of the merger contemplated by the Agreement and Plan of Merger dated April 18, 2022, among Checkmate Pharmaceuticals, Inc. (the \"Issuer\"), Regeneron Pharmaceuticals, and Scandinavian Acquisition Sub, Inc. (the \"Merger\"), each option granted by the Issuer to purchase Issuer Common Stock, whether or not vested, which has a per share exercise price that is less than $10.50 (each, an \"In the Money Issuer Option\") that was outstanding and unexercised as of immediately prior to the effective time of the Merger was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the total number of Issuer Common Stock subject to such In the Money Issuer Option and (2) the excess of $10.50 over the exercise price of such In the Money Issuer Option, subject to any required withholding of taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"At the effective time of the merger contemplated by the Agreement and Plan of Merger dated April 18, 2022, among Checkmate Pharmaceuticals, Inc. (the \"Issuer\"), Regeneron Pharmaceuticals, and Scandinavian Acquisition Sub, Inc. (the \"Merger\"), each option granted by the Issuer to purchase Issuer Common Stock, whether or not vested, which has a per share exercise price that is less than $10.50 (each, an \"In the Money Issuer Option\") that was outstanding and unexercised as of immediately prior to the effective time of the Merger was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the total number of Issuer Common Stock subject to such In the Money Issuer Option and (2) the excess of $10.50 over the exercise price of such In the Money Issuer Option, subject to any required withholding of taxes."}],"balance_after":0,"derivative":{"exercise_price":3.12,"expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":20061},"source":{"system":"sec-edgar","filing":"0000899243-22-020084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000089924322020084/doc4.xml","form_type":"4"}},{"id":2361344,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2022-03-02T21:48:20.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":6667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":6667,"derivative":{"exercise_price":1.38,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001437749-22-005081","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000143774922005081/rdgdoc.xml","form_type":"4"}},{"id":2466679,"issuer":{"id":126718,"kind":"organization","name":"Checkmate Pharmaceuticals, Inc.","symbol":"CMPI"},"owners":[{"id":73143,"kind":"person","name":"Yan Joy","position":1,"cik":"0001866109","reported_name":"Yan Joy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-17T20:22:48.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":20061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest 1/3 on the first anniversary of the grant date and monthly thereafter through the third anniversary of the grant date, subject to the Reporting Persons continued service through such date."}],"balance_after":20061,"derivative":{"exercise_price":3.12,"expiration_date":"2031-12-16","underlying":"Common Stock","underlying_shares":20061},"source":{"system":"sec-edgar","filing":"0000899243-21-048892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1866109/000089924321048892/doc4.xml","form_type":"4"}}]}